Most bought healthcare stocks in Q1 2016
See which Healthcare stocks institutional investors increased the most in Q1 2016, measured as net growth in reported share positions from Q4 2015 into Q1 2016. Notable additions at the top of this list include INNOVIVA INC (INVA), ASTRAZENECA PLC-SPONS ADR (AZN), ELI LILLY & CO (LLY), COMMUNITY HEALTH SYSTEMS INC (CYH). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| INVA | INNOVIVA INC | 23,041,974 | $290.10M | 2 | 0 | 0 | 0 | 2 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 14,989,368 | $325.00M | 0 | 2 | 0 | 1 | 3 |
| LLY | ELI LILLY & CO | 14,025,246 | $985.28M | 1 | 2 | 3 | 0 | 6 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 9,102,325 | $166.88M | 3 | 0 | 0 | 1 | 3 |
| ZTS | ZOETIS INC | 8,387,855 | $212.56M | 3 | 2 | 0 | 0 | 6 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 6,134,209 | -$39.93M | 0 | 4 | 1 | 0 | 5 |
| HCA | HCA HEALTHCARE INC | 2,935,923 | $232.67M | 1 | 1 | 0 | 1 | 2 |
| HALO | HALOZYME THERAPEUTICS INC | 2,732,800 | -$7.96M | 1 | 1 | 0 | 0 | 2 |
| DHR | DANAHER CORP | 2,235,631 | $275.33M | 1 | 5 | 2 | 1 | 9 |
| EDIT | EDITAS MEDICINE INC | 2,135,523 | $73.76M | 1 | 0 | 0 | 0 | 1 |
| IDXX | IDEXX LABORATORIES INC | 2,029,315 | $173.10M | 0 | 2 | 0 | 0 | 3 |
| UNH | UNITEDHEALTH GROUP INC | 1,766,132 | $505.11M | 2 | 5 | 3 | 0 | 10 |
| DVA | DAVITA INC | 1,762,852 | $294.68M | 1 | 2 | 1 | 0 | 5 |
| ALGN | ALIGN TECHNOLOGY INC | 1,550,687 | $124.88M | 1 | 1 | 1 | 0 | 3 |
| BAX | BAXTER INTERNATIONAL INC | 1,542,020 | $254.42M | 1 | 2 | 4 | 2 | 8 |
| PRGO | Perrigo Company PLC | 1,349,260 | $93.79M | 0 | 2 | 1 | 1 | 3 |
| SYK | STRYKER CORP | 1,187,582 | $228.00M | 1 | 2 | 2 | 1 | 5 |
| PTCT | PTC THERAPEUTICS INC | 948,700 | $6.11M | 1 | 0 | 0 | 0 | 1 |
| SNN | SMITH & NEPHEW PLC -SPON ADR | 809,200 | $26.27M | 0 | 1 | 0 | 0 | 1 |
| INCY | INCYTE CORP | 767,860 | $55.65M | 2 | 0 | 0 | 0 | 2 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 758,651 | $53.14M | 1 | 1 | 1 | 0 | 3 |
| ABBV | ABBVIE INC | 746,894 | $42.86M | 2 | 3 | 4 | 1 | 9 |
| OSUR | ORASURE TECHNOLOGIES INC | 720,700 | $6.77M | 0 | 1 | 0 | 0 | 1 |
| CMRX | CHIMERIX INC | 640,388 | $3.27M | 1 | 0 | 0 | 0 | 1 |
| DXCM | DEXCOM INC | 610,489 | $31.75M | 1 | 1 | 0 | 0 | 2 |
| CPIX | CUMBERLAND PHARMACEUTICALS | 565,411 | $1.28M | 0 | 2 | 0 | 0 | 2 |
| ARAY | ACCURAY INC | 505,877 | $716.00K | 0 | 1 | 0 | 0 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | 478,260 | $74.63M | 0 | 1 | 1 | 0 | 2 |
| SGMO | SANGAMO THERAPEUTICS INC | 474,391 | $1.61M | 0 | 2 | 0 | 0 | 2 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 467,937 | $61.44M | 2 | 2 | 0 | 0 | 4 |
| EXEL | EXELIXIS INC | 457,569 | $926.00K | 0 | 1 | 0 | 0 | 1 |
| GERN | GERON CORP | 453,480 | $1.02M | 1 | 0 | 0 | 0 | 2 |
| BRKR | BRUKER CORP | 441,110 | $12.35M | 1 | 0 | 0 | 0 | 1 |
| MD | PEDIATRIX MEDICAL GROUP INC | 438,392 | $28.32M | 1 | 0 | 0 | 1 | 1 |
| GILD | GILEAD SCIENCES INC | 424,445 | -$50.59M | 1 | 10 | 3 | 0 | 14 |
| THC | TENET HEALTHCARE CORP | 348,405 | $10.08M | 1 | 0 | 0 | 0 | 1 |
| GMED | GLOBUS MEDICAL INC - A | 346,700 | $8.23M | 1 | 0 | 0 | 0 | 1 |
| XRAY | DENTSPLY SIRONA INC | 309,375 | $19.07M | 2 | 0 | 0 | 0 | 2 |
| LFCR | LIFECORE BIOMEDICAL INC | 286,407 | $1.20M | 0 | 1 | 1 | 0 | 2 |
| AMED | AMEDISYS INC | 282,600 | $16.80M | 0 | 1 | 0 | 0 | 1 |
| AZTA | AZENTA INC | 271,143 | $2.66M | 0 | 1 | 1 | 0 | 2 |
| MDXG | MIMEDX GROUP INC | 253,425 | $2.20M | 1 | 1 | 0 | 0 | 2 |
| ATR | APTARGROUP INC | 230,400 | $19.60M | 0 | 1 | 0 | 0 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 225,862 | $34.44M | 0 | 2 | 3 | 0 | 6 |
| PDCO | PATTERSON COS INC | 224,605 | $20.82M | 0 | 2 | 1 | 0 | 4 |
| HCSG | HEALTHCARE SERVICES GROUP | 221,498 | $8.37M | 0 | 1 | 0 | 1 | 1 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 211,700 | $13.22M | 1 | 0 | 0 | 1 | 1 |
| RGEN | REPLIGEN CORP | 200,300 | $4.22M | 0 | 1 | 0 | 0 | 1 |
| EXAS | EXACT SCIENCES CORP | 197,940 | $1.30M | 0 | 1 | 0 | 0 | 1 |
| ENZ | ENZO BIOCHEM INC | 196,800 | $958.00K | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q1 2016
What are the most bought Healthcare stocks in Q1 2016?
The most bought healthcare stocks in Q1 2016 are those with the largest increase in reported share counts across institutional investors compared to Q4 2015, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2016?
Among filers in this sector, net additions were largest in companies such as INNOVIVA INC (INVA), ASTRAZENECA PLC-SPONS ADR (AZN), ELI LILLY & CO (LLY), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2015).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.